Can hypertension be prevented? The Danish Hypertension Prevention Project and the Trial of Prevention of Hypertension studies

Karin Skov, Stevo Julius, Shawna Nesbitt, Michael J. Mulvany

Research output: Contribution to journalReview article

8 Scopus citations

Abstract

Essential hypertension, a major health problem worldwide, is a disease generally considered to require life-long treatment. However, evidence suggests that hypertension is caused by specific phenotypic changes caused by the combination of genetic and environmental factors. Thus, in principle, hypertension could be prevented by prevention of these phenotypic changes. Animal data indicate that early treatment that blocks the renin-angiotensin system have long-term effects after treatment withdrawal. Here we report on two human trials that are testing whether early treatment (with the AT1-antagonist, candesartan) is able to have a persistent effect after stopping treatment: the Danish Hypertension Prevention Project and Trial of Prevention of Hypertension.

Original languageEnglish (US)
Pages (from-to)380-384
Number of pages5
JournalCurrent Opinion in Cardiology
Volume17
Issue number4
DOIs
StatePublished - Jan 1 2002

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Can hypertension be prevented? The Danish Hypertension Prevention Project and the Trial of Prevention of Hypertension studies'. Together they form a unique fingerprint.

  • Cite this